The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma
- PMID: 18338334
- DOI: 10.1002/path.2330
The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma
Abstract
Transmembrane serine protease 2 (TMPRSS2) is an androgen-regulated member of the type two transmembrane protease (TTSP) family. Two other members of the TTSP family, matriptase and hepsin, are over-expressed in prostate adenocarcinoma and mechanistically influence cancer cell invasion and metastasis. This study was performed to determine TMPRSS2 protein expression in primary and metastatic prostate cancers. We developed a monoclonal antibody capable of the sensitive and specific detection of TMPRSS2 protein. TMPRSS2 regulation by androgen and presence in seminal fluid was measured. TMPRSS2 localization and expression was evaluated in 415 cases of primary prostate cancer and 144 prostate cancer metastases by immunohistochemistry. We determined that TMPRSS2 protein expression is regulated by androgens and that TMPRSS2 is a component of the normal seminal fluid proteome. TMPRSS2 protein is abundantly expressed in the prostate, with low levels in the epithelia of the colon, stomach, epididymis and breast. Pancreatic acini, hepatic bile ducts, testicular Leydig cells and the kidney also express TMPRSS2. In the prostate, TMPRSS2 protein is specifically localized to the secretory epithelium, with enhanced expression in the plasma membrane orientated towards the ductal lumen. TMPRSS2 expression was significantly higher in both neoplastic prostate and in the epithelium of prostatic hyperplasia compared to normal epithelium (p < 0.01). TMPRSS2 expression was further elevated in higher Gleason grade cancers (patterns 4 and 5) compared to pattern 3 (p = 0.04). Furthermore, in most high-grade cancers, TMPRSS2 was mislocalized, being expressed in the cytoplasm as well as in the cell membrane. Prostate cancer metastases also generally expressed high levels of TMPRSS2. In summary, the TMPRSS2 protease is expressed highly in primary and metastatic prostate cancers and is associated with tumour cell differentiation. Based on studies with the related proteins matriptase and hepsin, TMPRSS2 should be investigated for causal roles in prostate carcinogenesis.
Copyright (c) 2008 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Similar articles
-
Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia.Cancer Res. 2001 Feb 15;61(4):1686-92. Cancer Res. 2001. PMID: 11245484
-
Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer.J Urol. 2003 Apr;169(4):1316-9. doi: 10.1097/01.ju.0000050648.40164.0d. J Urol. 2003. PMID: 12629351
-
Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer.Cancer Res. 2006 Sep 1;66(17):8347-51. doi: 10.1158/0008-5472.CAN-06-1966. Cancer Res. 2006. PMID: 16951141
-
The discovery of common recurrent transmembrane protease serine 2 (TMPRSS2)-erythroblastosis virus E26 transforming sequence (ETS) gene fusions in prostate cancer: significance and clinical implications.Adv Anat Pathol. 2009 May;16(3):145-53. doi: 10.1097/PAP.0b013e3181a12da7. Adv Anat Pathol. 2009. PMID: 19395877 Review.
-
Seminal fluid characterization for male fertility and prostate cancer: kallikrein-related serine proteases and whole proteome approaches.Semin Thromb Hemost. 2007 Feb;33(1):87-99. doi: 10.1055/s-2006-958467. Semin Thromb Hemost. 2007. PMID: 17253195 Review.
Cited by
-
Use of protease substrate specificity screening in the rational design of selective protease inhibitors with unnatural amino acids: Application to HGFA, matriptase, and hepsin.Protein Sci. 2024 Aug;33(8):e5110. doi: 10.1002/pro.5110. Protein Sci. 2024. PMID: 39073183
-
Updates in the pathophysiology of COVID-19 infection in male reproductive and sexual health: a literature review.Front Endocrinol (Lausanne). 2024 Feb 26;14:1226858. doi: 10.3389/fendo.2023.1226858. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38468633 Free PMC article. Review.
-
Antiandrogens as Therapies for COVID-19: A Systematic Review.Cancers (Basel). 2024 Jan 10;16(2):298. doi: 10.3390/cancers16020298. Cancers (Basel). 2024. PMID: 38254788 Free PMC article. Review.
-
Significance of Furin Expression in Thyroid Neoplastic Transformation.Cancers (Basel). 2023 Aug 1;15(15):3909. doi: 10.3390/cancers15153909. Cancers (Basel). 2023. PMID: 37568724 Free PMC article.
-
Apalutamide Prevents SARS-CoV-2 Infection in Lung Epithelial Cells and in Human Nasal Epithelial Cells.Int J Mol Sci. 2023 Feb 7;24(4):3288. doi: 10.3390/ijms24043288. Int J Mol Sci. 2023. PMID: 36834705 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical